GlassScriptPhysician profile
Rita L Fowler
NPI 1356579478
$7,249.32
in general payments reported to CMS, 2019-2025
41 companies · $2,510 in 2025
The $2,510 reported for 2025 was more than what 95% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,102 · 2022: $1,174 · 2023: $1,208 · 2024: $1,255 · 2025: $2,510.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,035 · Travel and Lodging: $938.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,034.75 |
| Travel and Lodging | $937.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,696.24 | 2021-2025 | |
| Boston Scientific Corporation | $1,553.62 | 2021-2025 | General - Therapies, Wavewriter Alpha Prime 16, Intracept |
| Lundbeck LLC | $519.97 | 2021-2025 | Vyepti |
| Scilex Pharmaceuticals INC. | $408.46 | 2021-2024 | Ztlido |
| Collegium Pharmaceutical, INC. | $354.40 | 2021-2025 | Xtampza, Belbuca |
| Biohaven Pharmaceutical Holding Company LTD. | $268.74 | 2022 | |
| Pfizer INC. | $247.34 | 2021-2025 | |
| Amgen INC. | $227.87 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $224.18 | 2021-2025 | Relistor |
| Forte Bio-Pharma LLC | $167.23 | 2022-2025 | Prolate, Nalocet, Tanlor |
| Lilly USA, LLC | $144.50 | 2021-2024 | Emgality |
| Teva Pharmaceuticals USA, INC. | $109.60 | 2021-2024 | Ajovy |
| Tersera Therapeutics LLC | $104.38 | 2021-2025 | Prialt |
| Vertex Pharmaceuticals Incorporated | $102.98 | 2024-2025 | |
| Si-Bone, INC. | $93.38 | 2021-2025 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $89.90 | 2022-2025 | Eterna |
| Grt US Holding, INC. | $88.87 | 2022 | |
| Averitas Pharma INC. | $80.44 | 2023-2024 | Qutenza |
| Impel Pharmaceuticals INC. | $76.29 | 2022-2023 | Trudhesa |
| Arbor Pharmaceuticals, INC. | $72.87 | 2021-2022 | |
| Protega Pharmaceutials INC | $72.86 | 2025 | Roxybond |
| Azurity Pharmaceuticals, INC. | $59.97 | 2023-2024 | Horizant, Horizant |
| Medtronic, INC. | $57.67 | 2021-2024 | Intellis Adaptivestim |
| Spr Therapeutics, INC | $48.00 | 2024-2025 | Sprint Pns System |
| Ipsen Biopharmaceuticals, INC | $47.03 | 2025 | Dysport |
| Mml US, INC. | $45.74 | 2025 | Reactiv8 |
| Axsome Therapeutics, INC. | $30.04 | 2025 | Symbravo |
| Vertos Medical, INC. | $29.09 | 2024 | Mild Device Kit |
| Currax Pharmaceuticals LLC | $28.32 | 2021-2022 | |
| Biodelivery Sciences International, INC. | $25.74 | 2021 | |
| Indivior INC. | $21.24 | 2024 | Sublocade |
| Pacira Pharmaceuticals Incorporated | $20.52 | 2024 | Iovera, Zilretta, Exparel |
| Fidia Pharma USA INC. | $18.88 | 2025 | Hymovis |
| Allergan, INC. | $18.48 | 2021 | |
| Nalu Medical, INC. | $18.46 | 2024 | Nalu Neurostimulation System |
| Biotronik Nro, INC. | $16.51 | 2025 | Prospera |
| Mdd US Operations, LLC | $14.97 | 2022 | |
| Tonix Medicines, INC. | $14.90 | 2025 | Tonmya |
| Horizon Therapeutics Plc | $12.69 | 2021 | |
| Merck Sharp & Dohme LLC | $12.58 | 2022 | |
| Relievant Medsystems, INC. | $4.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rita Fowler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.